First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients

• Main Authors: Christof Vulsteke (Author), Laurens De Cocker (Author), Alfonso Gómez de Liaño (Author), Cristina Montesdeoca (Author), Astrid De Meulenaere (Author), Lieselot Croes (Author), Danielle Delombaerde (Author), Bernadett Szabados (Author), Thomas Powles (Author)
• 格式: 圖書
• 出版: MDPI AG, 2023-03-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Enfortumab vedotin (EV), an antibody-drug conjugate directed against Nectin-4, significantly prolonged survival compared to standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma who previously received platinum-based chemotherapy and a PD-1 or PD-L1 inhibitor. Th...